Co-ot, Avrielle .

HRN: 26-52-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2025
CEFUROXIME 1.5GM (VIAL)
10/25/2025
10/31/2025
IV
270mg
Q8
PCAP
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: